Lipisperse™ Technology
Enabling the therapeutic potential of Levagen+™ Palmidrol (Palmitoylethanolamide [PEA]) requires enhanced absorption due to the suboptimal water-soluble properties of this lipid group. LipiSperse®, a mixture of surfactants, polar lipids and solvents, is a novel delivery system scientifically formulated to increase the dispersion of lipophilic agents in aqueous environments. By preventing agglomeration in the gastrointestinal tract, LipiSperse® increases the surface area of PEA resulting in enhanced absorption and significantly increased plasma PEA concentrations compared with standard PEA formulations.
Palmidrol (PEA)
PEA, an endogenous acyl ethanonolamide, is a saturated fatty acid derived from palmitic acid that is synthesized within the lipid bilayer of cell membranes in various body tissues as required in response to stress, injury or pain. Elevated levels of PEA have been observed systemically and locally in chronic pain conditions and during tissue injury and inflammation processes.
Unavailable
Choose your language and currency
